History of Lung Diseases: Inherited, Genetic, & Congenital
| Disease Category & Link | Progress, Diagnosis, Treatment, & Notable People |
| Cystic Fibrosis (CF) | Progress: Known in folklore as the “salty baby” disease. First clinically defined by Dr. Dorothy Andersen in 1938. In 1953, Paul di Sant’Agnese linked the disease to the high salt content in sweat. The major leap was the discovery of the CFTR gene in 1989 by Francis Collins, Lap-Chee Tsui, and John Riordan.
Diagnosis & Imaging:
Treatment: Evolved from “postural drainage” (physiotherapy) and antibiotics to the revolutionary CFTR modulator drugs (e.g., Trikafta) that correct the underlying protein defect. |
| Alpha-1 Antitrypsin (A1AT) Deficiency | Progress: A genetic disorder where the liver doesn’t produce enough A1AT protein, which is needed to protect the lungs from enzymes. This was discovered in 1963 by two Swedes, Carl-Bertil Laurell and Sten Eriksson, who noticed a missing protein band in patients with early-onset emphysema.
Diagnosis & Imaging:
Treatment: Smoking cessation is paramount. The specific treatment is augmentation therapy (a weekly IV infusion of the missing A1AT protein). |
| Primary Ciliary Dyskinesia (PCD) / Kartagener’s | Progress: A rare genetic disorder of defective cilia, the tiny hairs that clear mucus from the airways.
Kartagener’s Syndrome: A subtype of PCD described by Manes Kartagener in 1933, defined by the “Kartagener’s triad”:
Diagnosis & Imaging:
Treatment: No cure. Management is focused on aggressive airway clearance and antibiotics for frequent infections. |
| Lymphangioleiomyomatosis (LAM) | Progress: A rare, progressive disease affecting almost exclusively women of childbearing age. It involves the abnormal growth of smooth muscle-like cells and is linked to the Tuberous Sclerosis Complex (TSC) genes.
Diagnosis & Imaging:
Treatment: For decades, there was no treatment. The discovery of the mTOR pathway’s role led to the first effective therapy: Sirolimus (Rapamycin), which can halt disease progression. |
1. Notables Who Advanced Diagnosis & Management of Congenital and Inherited Lung Disease
| Name & Wikipedia Link | Comment on Contribution |
| Dorothy Andersen | (1901–1963) A pathologist who, in 1938, provided the first clear clinical and pathological description of Cystic Fibrosis (CF), distinguishing it from celiac disease and coining its name. |
| Paul di Sant’Agnese | (1914–2005) A pediatrician who, during a 1952 heatwave, noticed that “salty babies” were dying of heat stroke. He investigated and discovered the sweat chloride defect, leading to the development of the “sweat test,” which remains the gold standard for diagnosing CF. |
| Lap-Chee Tsui, Francis Collins, & John Riordan | In 1989, this team of geneticists discovered the CFTR gene and the specific F508del mutation responsible for most cases of Cystic Fibrosis. This breakthrough is the foundation for all modern CFTR modulator therapies. |
| Carl-Bertil Laurell & Sten Eriksson | (1919–2001) & (1930–2016) Swedish researchers who, in 1963, discovered Alpha-1 Antitrypsin (A1AT) Deficiency. They noticed that several patients with early-onset emphysema were missing a specific protein band on their tests, identifying a new genetic disease. |
| Manes Kartagener | (1897–1975) A Swiss internist who, in 1933, described the specific triad of situs inversus (organs on the wrong side), chronic sinusitis, and bronchiectasis. This “Kartagener’s Syndrome” is now known to be a subtype of Primary Ciliary Dyskinesia (PCD). |
2. Notables Who Suffered From Congenital and Inherited Lung Disease
| Name & Wikipedia Link | Comment on Disease |
| Frédéric Chopin | (1810–1849) The composer’s chronic respiratory illness and death at 39 were attributed to tuberculosis. However, modern analysis of his life and his sister’s (who died similarly) suggests he may have had Cystic Fibrosis or A1AT Deficiency. |
| Frank Deford | (1938–2017) While the famed sportswriter did not suffer from it, his daughter Alexandra did, dying from Cystic Fibrosis in 1980 at age 8. He became a passionate advocate and was the long-time chairman of the Cystic Fibrosis Foundation. |
| Gunnar Ekelöf | (1907–1968) A prominent Swedish poet who was one of the original patients in the 1963 study that first identified Alpha-1 Antitrypsin (A1AT) Deficiency. |
| Don Garlett | (1958–2022) A former NFL player (Cleveland Browns) who was diagnosed with Alpha-1 Antitrypsin (A1AT) Deficiency, which led to his need for a lung transplant. |
| Gunnar Larsson | (b. 1951) A Swedish Olympic gold medalist (swimming) who was diagnosed with Alpha-1 Antitrypsin (A1AT) Deficiency, though he is largely asymptomatic. |